Instrument Inactif

Communiqués 3D Medical Ltd Australian S.E.

Actions

Cours en clôture Australian S.E. Autres places de cotation
- ^AUD	-

24/04	Mach7 Technologies affiche une augmentation de 20 % de ses revenus récurrents annuels à 22,3 millions de dollars australiens pour le trimestre de mars	MT
24/04	Transcript : Mach7 Technologies Limited, Q3 2024 Earnings Call, Apr 24, 2024

Morgans rates M7T as Add	15/12	AQ
Morgans rates M7T as Add	04/07/23	AQ
Morgans rates M7T as Add	30/08/22	AQ
Mach7 Technologies : Quarterly Activities/App 4C Business Update	21/07/22	PU
Mach7 Technologies : Application for quotation of securities - M7T	19/04/22	PU
Mach7 Technologies : Notification regarding unquoted securities - M7T	19/04/22	PU
Mach7 Technologies : Notification regarding unquoted securities - M7T	13/01/22	PU
Mach7 Technologies : Application for quotation of securities - M7T	11/01/22	PU
Mach7 Technologies : Notification regarding unquoted securities - M7T	16/11/21	PU
Mach7 AGM 2021 Presentation	11/11/21	PU
M7T CEO to present at Bell Potter Healthcare Conference	08/11/21	PU
Mach7 Technologies : Announces Successful Go-Live at Sentara Martha Jefferson Hospital	13/10/21	AQ
Mach7 Technologies : Top 10 Features to Look For in an Enterprise Imaging Solution	15/09/21	PU
Mach7 Technologies : Receives Multiple 2021 Industry Awards	27/07/21	AQ
Mach7 Technologies : Recruits New Vice President of Global Sales	08/06/21	AQ
Mach7 Technologies : Top 10 Features to Demand of a Diagnostic Quality Enterprise Viewer	02/06/21	PU
Mach7 Technologies : Enterprise Imaging Done Differently	11/02/21	PU
Mach7 Technologies : Morgans rates M7T as Add	29/10/20	AQ
Mach7 Technologies : Annual Report to Shareholders FY20	16/10/20	PU
Mach7 Technologies : Appendix 4G	16/10/20	PU

Aucun résultat pour cette recherche